Share Johnson & Johnson Stock Price Prediction: 2026–2030 Outlook

Johnson & Johnson (JNJ) stock price prediction

Johnson & Johnson (JNJ) is listed in our stock directory under Drug Manufacturers - General in the Healthcare sector. Review the available dated company research, financial history and market context below to assess a price outlook.

Earnings research · Company research overview ·

EARNINGS & COMPANY RESEARCH

JNJ earnings, valuation & price action

View in calendar ↗
NEXT EXPECTED REPORTJan 26 2027Time unconfirmed · ET
EPS ESTIMATE2.91
REVENUE ESTIMATE26.4B

Expected dates may change. Estimates use the source’s reporting currency. Quotes and research are snapshots, not live prices.

COMPANY RESEARCH · Healthcare

Johnson & Johnson JNJ

Drug Manufacturers - General · Updated 11/20/2026

Adjusted closing price · USD267.14 Nov 19
159203247291Nov 18May 21Nov 19
Price50-day average200-day average+36.6% in view
VALUATION & EXPECTATIONS
Trailing P/E43.2×
Forward P/E24.0×
Trailing P/S6.9×
Forward P/S6.8×
EPS beat rate88%
Revenue beat rate100%
Positive window50%

EPS beats: 7 of 8 comparable reports. Positive price windows: 4 of 8.

Market caps may be up to 14 days old; prices up to seven days old; ratios and analyst estimates up to fourteen days old. Forward multiples use consensus for the fiscal year ending 2026-12-28, not the next 12 months. Negative or unavailable earnings multiples show “N/A”. Forward ADR multiples are omitted when the currency/share basis is not reconciled.

50-day average267.33
200-day average249.26
RSI (14)45
20-day range263.81 – 285.75
Relative volume1.3×
1-year change+36.6%
Last eight reported earnings for JNJ
Report dateEPS estimateEPS actualSurpriseResultRevenue actualPrice window*5 sessions*
Oct 13 20262.522.59+2.8%Beat25.4B-3.7%-1.7%
Jul 15 20262.852.90+1.8%Beat25.31B-1.5%+0.7%
Apr 14 20262.682.70+0.7%Beat24.06B+0.3%-5.0%
Jan 21 20262.462.460.0%Met24.56B+0.1%+4.4%
Oct 14 20252.762.80+1.4%Beat23.99B+0.1%+0.5%
Jul 16 20252.682.77+3.4%Beat23.74B+5.0%+9.0%
Apr 15 20252.582.77+7.4%Beat21.89B-0.3%+0.7%
Jan 22 20251.992.04+2.5%Beat22.52B-1.0%+2.0%

*Adjusted close before the report date to the first (or fifth) trading close after it. This window can span two sessions and is not an isolated earnings-day return. Figures may be revised by the provider.

Smart Money activity

Recent insider and politician transactions, and disclosed fund positions for JNJ.

Get Pro to see what insiders are doing ahead of earnings.

Explore insider trades, fund holdings and politician activity with an active Pro membership.

Checking membership…

02 / FINANCIALS

Johnson & Johnson financials

Revenue, earnings, cash flow and financial strength in one view.

Reporting currency unconfirmed.

Revenue
Net income
Gross profit
Operating income
EBITDA
Operating cash flow
Capital expenditure
Cash
Total assets
Total liabilities
Shareholder equity
Total debt
Net profit margin
Gross margin
Short interest: days to cover
How to read these financial metrics

Figures use the app’s saved statements for the displayed period, not a trailing-year total. Margins divide profit by revenue; quick ratio uses current assets less inventory divided by current liabilities. Compare dates and currencies before comparing companies.

03 / WHAT COMES NEXT

Johnson & Johnson event catalysts

Company earnings and scheduled market events that may change expectations.

2027-01-26

JNJ earnings

Watch reported results, management’s outlook and the share-price reaction.

See earnings expectations ↑
2026-11-2010:00 AM ET

Consumer sentiment · final

Watch changes in inflation expectations as well as sentiment.

Release schedule ↗Scheduled
2026-11-20Contract-specific cutoff

Monthly options expiration

Check your contract. Position unwinds and hedging can affect trading volume.

Release schedule ↗Scheduled
2026-11-20Time not announced

Russell · membership list update

Track revisions before the effective date; index flows do not guarantee a price rise.

Release schedule ↗Scheduled
2026-11-258:30 AM ET

Durable goods orders

Read core capital-goods orders alongside the headline; aircraft orders can create large swings.

Release schedule ↗Scheduled
2026-11-258:30 AM ET

Initial jobless claims

Use the multiweek trend; a single reading can be noisy. Thanksgiving release moves to Wednesday.

Release schedule ↗Scheduled
2026-11-258:30 AM ET

PCE inflation & consumer spending

Compare core PCE and real spending with expectations to assess inflation alongside demand.

Release schedule ↗Scheduled
2026-11-258:30 AM ET

Q3 GDP · second estimate

Separate consumer demand from inventory and trade effects; revisions can change the growth picture.

Release schedule ↗Scheduled
2026-11-2510:00 AM ET

New home sales

Watch demand, inventories and revisions when assessing homebuilders and rate-sensitive sectors.

Release schedule ↗Scheduled

Dates use U.S. Eastern time and can change. Calendar events provide context; they do not determine the direction of a stock move.

04 / SIDE BY SIDE

Compare JNJ with its peers

Drug Manufacturers - General · Compare valuation, financial strength and price performance.

Companies with valuation data7
Peer median positive P/E25.2×
JNJ P/E43.2×
JNJ peer comparison: valuation
CompanyPriceMarket capP/EForward P/EP/SForward P/S
JNJJohnson & Johnson2026-11-19 · USD267.14685.37B43.2×24.0×6.9×6.8×
ABBVAbbVie Inc.2026-11-19 · USD283.54520.86B50.2×20.2×7.8×7.7×
AMGNAmgen Inc.2026-11-19 · USD438.82237.36B25.2×18.6×6.1×6.0×
AZNAstraZeneca PLC2026-11-19 · USD175.41285.39B26.0×17.1×4.6×4.6×
BMYBristol-Myers Squibb Company2026-11-18 · USD59.56121.75B13.2×9.2×2.4×2.4×
GILDGilead Sciences, Inc.2026-11-19 · USD167.52207.83B6.7×6.6×
GSKGSK plc2026-11-19 · USD47.9996.17B16.9×2.2×
JNJ43.2×
ABBV50.2×
AMGN25.2×
AZN26.0×
BMY13.2×
GSK16.9×

The peer median excludes the selected stock and is based on 5 available positive multiples. P/E median excludes negative or missing earnings multiples. Peer reports can have different fiscal periods and currencies; values are not currency-converted.

05 / PEER ANALYSIS

Explore JNJ alongside its peers

Drug Manufacturers - General · 15 companies · Cached market data

Comparison

Compare companies

Tap a bubble to inspect a company, then × to hide it. Undo restores the last company hidden. Bubble area reflects market cap, with a minimum size for visibility.

Price / sales
0.3×06.0×499.88B11.6×999.76B17.2×1.5TLLY · Eli Lilly and Market cap: 1.35T Price / sales: 15.6×ABBV · AbbVie Market cap: 520.86B Price / sales: 7.8×MRK · Merck & Market cap: 325.88B Price / sales: 4.8×NVS · Novartis AG Market cap: 302.56B Price / sales: 5.6×AZN · AstraZeneca Market cap: 285.39B Price / sales: 4.6×AMGN · Amgen Market cap: 237.36B Price / sales: 6.1×GILD · Gilead Sciences Market cap: 207.83B Price / sales: 6.7×NVO · Novo Nordisk A/S Market cap: 171.45B Price / sales: 3.5×PFE · Pfizer Market cap: 162.22B Price / sales: 2.5×BMY · Bristol-Myers Squibb Market cap: 121.75B Price / sales: 2.4×SNY · Sanofi Market cap: 112.88B Price / sales: 2.0×GSK · GSK plc Market cap: 96.17B Price / sales: 2.2×JNJ · Johnson & Johnson Market cap: 685.37B Price / sales: 6.9×Hide JNJ · Undo restores itMarket cap
JNJJohnson & Johnson

Market cap: 685.37B
Price / sales: 6.9×

Valuation snapshot: 2026-11-19
13 of 15 companies have both plotted values.

P/S distribution

Trailing price-to-sales multiples · 13 companies

Median P/S4.8×
Middle 50%2.5× to 6.7×
JNJ P/S6.9×
JNJ
1.8×8.2×

Tap a bar to see the companies in that P/S range. JNJ has a higher P/S than 77% of this group.

2 companies excluded from P/S statistics because sales are non-positive or the saved multiple is missing. Statistics include all valid positive values, including those outside the focused chart range.

Companies

Showing 8 of 15 matching companies · Largest market cap first

  • Market cap 1.35TP/E 46.4×P/S 15.6×Forward P/E Forward P/S Price snapshot: 2026-11-19
    ↗
  • Market cap 685.37BP/E 43.2×P/S 6.9×Forward P/E Forward P/S Price snapshot: 2026-11-19
    ↗
  • Market cap 520.86BP/E 50.2×P/S 7.8×Forward P/E Forward P/S Price snapshot: 2026-11-19
    ↗
  • Market cap 325.88BP/E 133.5×P/S 4.8×Forward P/E Forward P/S Price snapshot: 2026-11-19
    ↗
  • Market cap 302.56BP/E 31.1×P/S 5.6×Forward P/E Forward P/S Price snapshot: 2026-11-19
    ↗
  • Market cap 285.39BP/E 26.0×P/S 4.6×Forward P/E Forward P/S Price snapshot: 2026-11-19
    ↗
  • Market cap 237.36BP/E 25.2×P/S 6.1×Forward P/E Forward P/S Price snapshot: 2026-11-19
    ↗
  • Market cap 207.83BP/E P/S 6.7×Forward P/E Forward P/S Price snapshot: 2026-11-19
    ↗

Explore industries

Open an industry for its comparison, valuation and companies.

U.S.-listed companies from the app’s catalog. Medians use saved positive P/E values; coverage and snapshot dates vary.

How this comparison works

Uses the saved companies from the same industry and listing market, including JNJ, ordered by cached market cap. Company snapshots can have different dates; the web cache may cover fewer metrics and periods than the app.

Periods end at each company’s dated price snapshot. Change compares the latest saved observation with one at or before the selected period’s start. A daily price change uses consecutive saved sessions. Financial data updates quarterly, so short periods may show no change. Missing history and zero starting values are excluded; a negative starting value uses its absolute value as the denominator.

Metrics use saved ratios and percentages. Market caps use the listing market’s reporting currency; underlying financial statements may use different currencies. Circle sizes have a minimum for touch visibility, and an outlined circle indicates a missing market cap. These comparisons describe data, not recommendations or price predictions.

Smart Money activity

Recent insider and politician transactions, and disclosed fund positions for JNJ.

Get Pro to see what insiders are doing ahead of earnings.

Explore insider trades, fund holdings and politician activity with an active Pro membership.

Checking membership…

What can move JNJ?

A price move may reflect company news, sector conditions or changes in the wider market. Check the timing and primary evidence before attributing a move to one headline.

  • Product demand and revenue growth
  • Research costs and operating margins
  • Regulatory decisions and clinical milestones
  • Competition and patent exposure
  • Cash generation and financing needs

Johnson & Johnson stock price prediction: 2027 outlook

What could JNJ be worth in 2027? A useful prediction starts with dated operating assumptions and a valuation range. This section is a research framework, not a published numerical price target. Use the company’s financial results and guidance to test the assumptions.

JNJ stock price prediction for tomorrow

For the next trading session, review company news, overnight market moves, trading volume and technical levels alongside the latest dated quote. A move before the open can reverse during regular trading. On weekends and market holidays, the next trading session is not necessarily tomorrow.

Review JNJ news · Review technical analysis

JNJ stock outlook for next week

Check whether earnings, company announcements or economic releases fall within the coming week. Compare JNJ with industry peers to distinguish company-specific moves from a sector-wide shift. A weekly view should identify the catalyst, the scenario it supports and what would invalidate that view.

Check earnings dates and results · Compare industry performance · Review the market calendar

Johnson & Johnson stock prediction for next month and the coming months

For December 2026, January 2027 and February 2027, review the earnings calendar, changes in company guidance and the trend in valuation and price. These are research windows, not separate monthly price targets. Reassess the outlook when new results or disclosures change the assumptions.

Compare insider purchases and sales with their disclosure dates and any verified trading-plan status. Unusual options volume can help identify activity worth investigating, but volume alone does not establish a bullish or bearish forecast.

Review available insider and fund activity · Explore earnings research

Johnson & Johnson stock price prediction for next year: 2027

A longer-term outlook depends on how the business develops and what investors are willing to pay for its earnings or cash flow. Review revenue growth, margins, debt, dilution and capital investment, then test a range of valuation assumptions. A strong business can still underperform if its share price already assumes stronger results.

What to watch for JNJ

Product demand and revenue growth; Research costs and operating margins; Regulatory decisions and clinical milestones; Competition and patent exposure; Cash generation and financing needs. Compare changes in these drivers with the assumptions behind any forecast, rather than relying on a target price alone.

2026, 2027, 2028, 2029 and 2030: a longer-term research roadmap

These calendar-year checkpoints describe what to investigate, not calculated share-price forecasts. As a year passes, compare the assumptions with reported results. Later years depend on more uncertain growth, profitability and valuation assumptions.

2026: establish the starting point
Review reported results, the latest dated share price and the valuation already implied by the market.
2027: test company execution
Track product demand and revenue growth against guidance and assess research costs and operating margins as new results become available.
2028: assess durability
Review whether growth can translate into sustainable cash flow, considering regulatory decisions and clinical milestones.
2029: reassess competitive and financial risks
Stress-test the outlook against competition and patent exposure, funding requirements and potential dilution.
2030: evaluate the long-term valuation range
Compare multiple growth and valuation scenarios, including the effect of cash generation and financing needs. More distant horizons require wider uncertainty ranges.

Bull, base and bear scenarios

  • Bull case: operating results exceed the stated assumptions and investors sustain a higher valuation.
  • Base case: revenue, profitability and cash flow broadly follow the assumptions being tested.
  • Bear case: business performance weakens, financing needs rise or the market pays a lower multiple.

Is a 12-month target the same as a 2027 prediction?

No. A rolling 12-month target runs from its publication date; a calendar-year forecast may refer to year-end. Check the analyst or model source, date, currency, earnings definition and horizon. Company guidance describes operating expectations, not a promised share price.

Explore JNJ valuation and company research →

Price and valuation

This page does not currently provide a verified live quote. Confirm the price, currency, market session and quote timestamp with your broker before making a decision. Valuation depends on earnings, growth expectations and the risks priced into the shares.

How to assess the next earnings report

Compare reported results with the previous year and with expectations from a dated, identified source. Separate reported earnings from adjusted figures, and read forward guidance and the cash-flow statement.

INDUSTRY COMPARISON

JNJ industry peers

Drug Manufacturers - General · Oct 16, 2026 · Closing-price performance

Compare JNJ with 7 other stocks in the available heatmap coverage.